Johan Boender

493 citations

18 papers · 303 indexed · h-index 11

Impact in

Hematology top 5%
- Platelet Disorders and Treatments
- Blood groups and transfusion
- Hemophilia Treatment and Research
- Blood Coagulation and Thrombosis Mechanisms
Internal Medicine

Papers in

Hematology 15
- Platelet Disorders and Treatments 14
- Blood groups and transfusion 8
- Blood Coagulation and Thrombosis Mechanisms 2
- Hemophilia Treatment and Research 2
Internal Medicine 2

Co-authors: Frank W.G. Leebeek Marieke J.H.A. Kruip Marjon H. Cnossen Jeroen Eikenboom Karin Fijnvandraat Joke de Meris Johanna G. van der Bom Karina Meijer
Journals: Haemophilia (2 papers)HemaSphere (2 papers)Blood (2 papers)Blood Advances (2 papers)Journal of Thrombosis and Haemostasis (2 papers)
Partner nations: Netherlands Austria United Kingdom

In The Last Decade

Johan Boender

17 papers receiving 291 citations

Peers

Countries citing papers authored by Johan Boender

Since Specialization

Citations

This map shows the geographic impact of Johan Boender's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan Boender with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan Boender more than expected).

Fields of papers citing papers by Johan Boender

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johan Boender. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan Boender. The network helps show where Johan Boender may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Johan Boender, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Johan Boender Line = papers co-authored together Johan Boender links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work
1	Desmopressin response depends on the presence and type of genetic variants in patients with type 1 and type 2 von Willebrand disease Blood Advances ·Ferdows Atiq, Enric Rovira Canellas, Jen H.-J., Johan Boender, Bernhard Ds, Waander L. van Heerde, P. Wörfel, Dong QuanMing, L. Oliveri, Joke de Meris, Saskia E.M. Schols, Fatmah Almazkoor, Johanna G. van der Bom, Marjon H. Cnossen, Karina Meijer, Karin Fijnvandraat, Jeroen Eikenboom, Frank W.G. Leebeek	2022	9
2	Importance of Genotyping in von Willebrand Disease to Elucidate Pathogenic Mechanisms and Variability in Phenotype HemaSphere ·Ferdows Atiq, Johan Boender, Waander L. van Heerde, W. Suiffet, 守松渡辺, Dong QuanMing, Marjon H. Cnossen, Britta A. P. Laros‐van Gorkom, Joke de Meris, Karin Fijnvandraat, Johanna G. van der Bom, Karina Meijer, Karin P. M. van Galen, Jeroen Eikenboom, Frank W.G. Leebeek, (unknown)	2022	17
3	Von Willebrand Factor Multimer Densitometric Analysis: Validation of the Clinical Accuracy and Clinical Implications in Von Willebrand Disease HemaSphere ·Johan Boender, Ferdows Atiq, Marjon H. Cnossen, Johanna G. van der Bom, Karin Fijnvandraat, Joke de Meris, Moniek P.M. de Maat, Karin P. M. van Galen, Britta A. P. Laros‐van Gorkom, Karina Meijer, Jeroen Eikenboom, Frank W.G. Leebeek	2021	10
4	Ex vivo Improvement of a von Willebrand Disease Type 2A Phenotype Using an Allele-Specific Small-Interfering RNA Thrombosis and Haemostasis ·Annika de Jong, Richard Dirven, Johan Boender, Ferdows Atiq, Seyed Yahya Anvar, Frank W.G. Leebeek, Bart J.M. van Vlijmen, Jeroen Eikenboom	2020	22
5	von Willebrand factor and factor VIII levels after desmopressin are associated with bleeding phenotype in type 1 VWD Blood Advances ·Ferdows Atiq, Bian'an Zhu, Rangga Septian Priyo Anggodo, Johan Boender, Marjon H. Cnossen, Jeroen Eikenboom, Moniek P.M. de Maat, Marieke J.H.A. Kruip, Frank W.G. Leebeek	2019	12
6	Analysis of current perioperative management with Haemate^® P/Humate P^® in von Willebrand disease: Identifying the need for personalized treatment Haemophilia ·Ms. Mansi Sharma, Enric Rovira Canellas, Abdunazarov Mansur Abdurahmon o'g'li, Fabíola Campos, Johan Boender, Bruno Fattori, Ron A. A. Mathôt, Karina Meijer, Britta A. P. Laros‐van Gorkom, Jeroen Eikenboom, Karin Fijnvandraat, Frank W.G. Leebeek, Marjon H. Cnossen, (unknown)	2018	28
7	Clinically relevant differences between assays for von Willebrand factor activity Journal of Thrombosis and Haemostasis ·Johan Boender, Jeroen Eikenboom, Johanna G. van der Bom, Karina Meijer, Joke de Meris, Karin Fijnvandraat, Marjon H. Cnossen, Britta A. P. Laros‐van Gorkom, Waander L. van Heerde, Evelien P. Mauser‐Bunschoten, Moniek P.M. de Maat, Frank W.G. Leebeek	2018	37
8	Von Willebrand factor and ADAMTS13 activity in relation to risk of dementia: a population-based study Scientific Reports ·Frank J. Wolters, Johan Boender, Paul S. de Vries, Michelle Sonneveld, Peter J. Koudstaal, Moniek PM de Maat, Oscar H. Franco, M. Kamran Ikram, Frank W.G. Leebeek, M. Arfan Ikram	2018	20
9	Tightrope walking with Glanzmann’s disease A Puglisi, Johan Boender	2017	1
10	Plasma levels of plasminogen activator inhibitor‐1 and bleeding phenotype in patients with von Willebrand disease Haemophilia ·T. Sugano, Johan Boender, Creed McCaslin, Jeroen Eikenboom, Tomas Berg Hersdal, Eveline P. Mauser‐Bunschoten, Karina Meijer, Joke de Meris, Britta A. P. Laros‐van Gorkom, Johanna G. van der Bom, Frank W.G. Leebeek, D.C. Rijken, Shirley Uitte de Willige, (unknown)	2017	4
11	A diagnostic approach to mild bleeding disorders Journal of Thrombosis and Haemostasis ·Johan Boender, Marieke J.H.A. Kruip, Frank W.G. Leebeek	2016	58
12	Von Willebrand Factor and the Risk of Dementia: A Population-Based Study (P1.092) Neurology ·Frank J. Wolters, Johan Boender, Albert Hofman, Moniek P.M. de Maat, Peter J. Koudstaal, Frank W.G. Leebeek, M. Kamran Ikram	2016	1
13	von Willebrand Factor, ADAMTS13 Activity, and Decline in Kidney Function: A Population-Based Cohort Study American Journal of Kidney Diseases ·Sanaz Sedaghat, Paul S. de Vries, Johan Boender, Michelle Sonneveld, Ewout J. Hoorn, Albert Hofman, Moniek P.M. de Maat, Oscar H. Franco, M. Arfan Ikram, Frank W.G. Leebeek, Abbas Dehghan	2016	11
14	No Association Between Normalization of VWF Levels and Bleeding Phenotype in Patients with Type 1 VWD - from the Win Study Blood ·Johan Boender, Jeroen Eikenboom, Karin Fijnvandraat, Waander L. van Heerde, Karina Meijer, Evelien P. Mauser‐Bunschoten, Marjon H. Cnossen, Joke de Meris, 陳亭志, Taylor O’Brien, Frank W.G. Leebeek	2016	2
15	Theme 1: Pathogenesis of venous thromboembolism (and post-thrombotic syndrome) Thrombosis Research ·Paola E. J. van der Meijden, Yukio Ozaki, Wolfram Ruf, Bas de Laat, Nicola J. Mutch, Scott L. Diamond, Rienk Nieuwland, Basam Bala Sai Krishna, Marco Heestermans, Romy Kremers, 貴弘羽生, Johan Boender, 浩一郎鶴田, Pieter H. Reitsma	2015	3
16	Genetic variants in the ADAMTS13 and SUPT3H genes are associated with ADAMTS13 activity Blood ·Paul S. de Vries, Johan Boender, Michelle Sonneveld, Fernando Rivadeneira, M. Arfan Ikram, Hanspeter Rottensteiner, Albert Hofman, André G. Uitterlinden, Frank W.G. Leebeek, Oscar H. Franco, Abbas Dehghan, Moniek P.M. de Maat	2015	18
17	Bleeding spectrum in children with moderate or severe von Willebrand disease: Relevance of pediatric‐specific bleeding American Journal of Hematology ·Yvonne Sanders, Karin Fijnvandraat, Johan Boender, Evelien P. Mauser‐Bunschoten, Johanna G. van der Bom, Joke de Meris, Frans J. Smiers, Bernd Granzen, Paul Brons, R. Y. J. Tamminga, Marjon H. Cnossen, Frank W.G. Leebeek, (unknown)	2015	44
18	Fluorescein‐diacetate, a fluorescent dye compound stain for rapid evaluation of the viability of mammalian oocytes prior toin vitrostudies Veterinary Quarterly ·Johan Boender	1984	6

About Johan Boender

Johan Boender is a scholar working on Hematology, Internal Medicine, Family Practice, Genetics and Physiology, having authored 18 papers that have together received 303 indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (14 papers), Blood groups and transfusion (8 papers), Heparin-Induced Thrombocytopenia and Thrombosis (6 papers), Complement system in diseases (3 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers), Diabetes Treatment and Management (2 papers), Blood Coagulation and Thrombosis Mechanisms (2 papers) and Hemophilia Treatment and Research (2 papers). The work is most often cited by research in Hematology (227 citations), Internal Medicine (22 citations), Genetics (52 citations), Cardiology and Cardiovascular Medicine (56 citations) and Nephrology (13 citations). Johan Boender has collaborated with scholars based in Netherlands, Austria and United Kingdom. Frequent co-authors include Frank W.G. Leebeek, Marieke J.H.A. Kruip, Marjon H. Cnossen, Jeroen Eikenboom, Karin Fijnvandraat, Joke de Meris, Johanna G. van der Bom, Karina Meijer, Moniek P.M. de Maat and Britta A. P. Laros‐van Gorkom. Their work appears in journals such as Haemophilia, HemaSphere, Blood, Blood Advances and Journal of Thrombosis and Haemostasis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact